Inventor · disambiguated record
Luis Barrera
Also filed as: BARRERA LUIS · BARRERA LUIS A · BARRERA LUIS ALBERTO
6 granted patents·12 pending applications·7 citations·filing 2009–2024
70Inventor score
Files withBEAM THERAPEUTICS INC6EDITAS MEDICINE INC6UNIV SAINT LOUIS2MONTANO SUAREZ ADRIANA M1PRIME MEDICINE INC1
Top patents by PatentIndex Score
18 records- 0182US7972593B2Delivery of therapeutic agents to the boneUNIV SAINT LOUIS·Filed 2009·Granted Jul 5, 2011·7 cites·5 claims
- 0270US2024360471A1Crispr/cas-related methods and compositions for treating beta hemoglobinopathiesEDITAS MEDICINE INC·Filed 2023·Application pending·0 cites
- 0369US2024327813A1Crispr enzymes, methods, systems and uses thereofBEAM THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0467US2024228988A1Compositions and methods for efficient genome editingPRIME MEDICINE INC·Filed 2024·Application pending·0 cites
- 0566US2024417706A1Systems and methods for the treatment of hemoglobinopathiesEDITAS MEDICINE INC·Filed 2023·Application pending·0 cites
- 0661US11844825B2Method of treating mucopolysaccharidosis type IVAUNIV SAINT LOUIS·Filed 2021·Granted Dec 19, 2023·0 cites·9 claims
- 0760US2024167008A1Novel crispr enzymes, methods, systems and uses thereofBEAM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0859US11851690B2Systems and methods for the treatment of hemoglobinopathiesEDITAS MEDICINE INC·Filed 2019·Granted Dec 26, 2023·0 cites·12 claims
- 0959US2024294914A1Compositions and methods for treating hepatitis b virus infectionBEAM THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1053US2023279373A1Novel crispr enzymes, methods, systems and uses thereofBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1152US2023070861A1Compositions and methods for treating hepatitis bBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1251US11963982B2CRISPR/RNA-guided nuclease systems and methodsEDITAS MEDICINE INC·Filed 2019·Granted Apr 23, 2024·0 cites·18 claims
- 1350US2022313799A1Compositions and methods for editing a mutation to permit transcription or expressionBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1449US11529397B2Method of treating mucopolysaccharidosis type IVAMONTANO SUAREZ ADRIANA M·Filed 2018·Granted Dec 20, 2022·0 cites·13 claims
- 1546US2020255857A1Crispr/cas-related methods and compositions for treating beta hemoglobinopathiesEDITAS MEDICINE INC·Filed 2017·Application pending·0 cites
- 1638US2011311487A1Delivery of therapeutic agents to the boneTOMATSU SHUNJI·Filed 2011·Application pending·0 cites
- 1737US11499151B2Methods and systems for analyzing guide RNA moleculesEDITAS MEDICINE INC·Filed 2018·Granted Nov 15, 2022·0 cites·19 claims
- 1834US2013202633A1Determination of immunogenic peptides in lysosomal enzymes and induction of oral toleranceSAINT LOUIS UNIVERSITY A NON PROFIT ORGANIZATION·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Luis Barrera files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →